The Kingdom of Morocco is among the first African countries that will administer the Covid 19 vaccine to its citizens in the coming weeks.
At the moment, at least 4, 425 people have died of Covid-19 in the North African country since March this year.
According to the results of clinical studies by the US based Pfizer and partner BioNTech, the safety, efficiency and immunogenicity of the vaccine have been proven.
Morocco’s National Scientific Committee has since stressed that the vaccination campaign is a real response to end the acute phase of the pandemic.
“This vaccine is faithful to the proactive royal approach adopted since the appearance of this virus. His Majesty the King Mohammed VI gave His High Guidelines for the launch, in the coming weeks, of a massive vaccination operation against Covid-19” says a statement from authorities in the capital, Rabat.
It adds “this unprecedented nationwide operation aims to provide the population with a vaccine as an appropriate means of immunizing against the virus and controlling its spread”.
This exercise will target citizens over 18 years of age in the two-injection vaccination schedule.
The statement explains that priority will be given in particular to front-line staff, in this case health workers, public authorities, security forces and national education workers, the elderly and people vulnerable to the virus, before extending it to the rest of the population.
The Moroccan Kingdom has been able to occupy an advanced rank in the procurement of Covid-19 vaccine, which led to the successful participation of the country in the clinical trials.
The King urges authorities to ensure the proper preparation and the smooth running of this large-scale national operation, at the health, logistical and technical levels.
He particularly emphasised on the accessibility of the vaccine, within a social and supportive framework, and its availability in sufficient quantities.
He further instructs relevant staff to ensure a smooth medical logistics of transport, storage, and administration of the vaccine throughout the country and the establishment of an efficient system of pre-registration of beneficiaries.
The US based Pfizer and partner BioNTech said on Monday that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement and relief in the face of the global pandemic.
The companies said an early analysis of the results showed that individuals who received two injections of the vaccine three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo.